Trientine hydrochloride is a copper chelating agent recommended for the treatment of Wilson's Disease, especially in patients intolerant of penicillamine therapy.
Unlike the latter agent, trientine is not indicated in cystinuria or rheumatoid arthritis.
Cambridge University (United Kingdom)
Triethylenetetramine Hydrochloride is a selective CuII-chelator; crosslinking agent. Triethylenetetramine is undergoing trials for the treatment of heart failure in patients with diabetes.
As thermosetting resin; epoxy curing agent; lubricating oil additive; analytical reagent for Cu, Ni.
ChEBI: Trientine hydrochloride is a secondary amino compound.
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Trientine Hydrochloride is administered for relief of symptoms of Wilson′s disease for penicillamine intolerance, hence is employed as an oral medication for the treatment of an inherited defect in copper metabolism.
